Monthly Communication Report

Registrant name:	Kate Dalgleish
Client:	Sunovion Pharmaceuticals Canada Inc.
Associated registration:	926625-367714-2
Communication date:	2020-12-09
Posted date:	2021-01-15

Designated Public Office Holders who participated in the communication:	Elena Lungu, Manager Policy Development, Patented Medicine Prices Review Board (PMPRB) Tanya Potashnik, Director Policy & Economic Analysis Branch, Patented Medicine Prices Review Board (PMPRB) Douglas Clark, Executive Director Patented Medicine Prices Review Board (PMPRB) Isabel Jaen Raasch, General Counsel Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication:	Health,  Research and Development